278 related articles for article (PubMed ID: 28819788)
1. Insulin-like growth factor-1 activates different catalytic subunits p110 of PI3K in a cell-type-dependent manner to induce lipogenesis-dependent epithelial-mesenchymal transition through the regulation of ADAM10 and ADAM17.
Park GB; Kim D
Mol Cell Biochem; 2018 Feb; 439(1-2):199-211. PubMed ID: 28819788
[TBL] [Abstract][Full Text] [Related]
2. TLR4-mediated galectin-1 production triggers epithelial-mesenchymal transition in colon cancer cells through ADAM10- and ADAM17-associated lactate production.
Park GB; Kim D
Mol Cell Biochem; 2017 Jan; 425(1-2):191-202. PubMed ID: 27837433
[TBL] [Abstract][Full Text] [Related]
3. Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells.
Park GB; Kim D; Kim YS; Kim JW; Sun H; Roh KH; Yang JW; Hur DY
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5162-73. PubMed ID: 26244291
[TBL] [Abstract][Full Text] [Related]
4. Ectodomain shedding of the cell adhesion molecule Nectin-4 in ovarian cancer is mediated by ADAM10 and ADAM17.
Buchanan PC; Boylan KLM; Walcheck B; Heinze R; Geller MA; Argenta PA; Skubitz APN
J Biol Chem; 2017 Apr; 292(15):6339-6351. PubMed ID: 28232483
[TBL] [Abstract][Full Text] [Related]
5. Trop-2 induces ADAM10-mediated cleavage of E-cadherin and drives EMT-less metastasis in colon cancer.
Guerra E; Trerotola M; Relli V; Lattanzio R; Tripaldi R; Vacca G; Ceci M; Boujnah K; Garbo V; Moschella A; Zappacosta R; Simeone P; de Lange R; Weidle UH; Rotelli MT; Picciariello A; Depalo R; Querzoli P; Pedriali M; Bianchini E; Angelucci D; Pizzicannella G; Di Loreto C; Piantelli M; Antolini L; Sun XF; Altomare DF; Alberti S
Neoplasia; 2021 Sep; 23(9):898-911. PubMed ID: 34320447
[TBL] [Abstract][Full Text] [Related]
6. Expression of ADAM17 and ADAM10 in nasal polyps.
Bae WY; Park SK; Kim do H; Koh TK; Hur DY; Chueh HW
Int Forum Allergy Rhinol; 2016 Jul; 6(7):731-6. PubMed ID: 27012683
[TBL] [Abstract][Full Text] [Related]
7. The xenoestrogens biphenol-A and nonylphenol differentially regulate metalloprotease-mediated shedding of EGFR ligands.
Urriola-Muñoz P; Li X; Maretzky T; McIlwain DR; Mak TW; Reyes JG; Blobel CP; Moreno RD
J Cell Physiol; 2018 Mar; 233(3):2247-2256. PubMed ID: 28703301
[TBL] [Abstract][Full Text] [Related]
8. Expression of the ectodomain-releasing protease ADAM17 is directly regulated by the osteosarcoma and bone-related transcription factor RUNX2.
Araya HF; Sepulveda H; Lizama CO; Vega OA; Jerez S; Briceño PF; Thaler R; Riester SM; Antonelli M; Salazar-Onfray F; Rodríguez JP; Moreno RD; Montecino M; Charbonneau M; Dubois CM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2018 Nov; 119(10):8204-8219. PubMed ID: 29923217
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Conditions That Affect the Selective Processing of Endogenous Notch1 by ADAM10 and ADAM17.
Alabi RO; Lora J; Celen AB; Maretzky T; Blobel CP
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33673337
[TBL] [Abstract][Full Text] [Related]
10. Induction of galectin-1 by TLR-dependent PI3K activation enhances epithelial-mesenchymal transition of metastatic ovarian cancer cells.
Park GB; Chung YH; Kim D
Oncol Rep; 2017 May; 37(5):3137-3145. PubMed ID: 28350104
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-D-glucose suppresses the migration and reverses the drug resistance of colon cancer cells through ADAM expression regulation.
Park GB; Chung YH; Kim D
Anticancer Drugs; 2017 Apr; 28(4):410-420. PubMed ID: 28059830
[TBL] [Abstract][Full Text] [Related]
12. A Disintegrin and Metalloproteinase10 (ADAM10) Regulates NOTCH Signaling during Early Retinal Development.
Toonen JA; Ronchetti A; Sidjanin DJ
PLoS One; 2016; 11(5):e0156184. PubMed ID: 27224017
[TBL] [Abstract][Full Text] [Related]
13. Mechanical activation of lung epithelial cells through the ion channel Piezo1 activates the metalloproteinases ADAM10 and ADAM17 and promotes growth factor and adhesion molecule release.
Grannemann C; Pabst A; Honert A; Schieren J; Martin C; Hank S; Böll S; Bläsius K; Düsterhöft S; Jahr H; Merkel R; Leube R; Babendreyer A; Ludwig A
Biomater Adv; 2023 Sep; 152():213516. PubMed ID: 37348330
[TBL] [Abstract][Full Text] [Related]
14. Cleavage Site Localization Differentially Controls Interleukin-6 Receptor Proteolysis by ADAM10 and ADAM17.
Riethmueller S; Ehlers JC; Lokau J; Düsterhöft S; Knittler K; Dombrowsky G; Grötzinger J; Rabe B; Rose-John S; Garbers C
Sci Rep; 2016 May; 6():25550. PubMed ID: 27151651
[TBL] [Abstract][Full Text] [Related]
15. The plasma membrane: Penultimate regulator of ADAM sheddase function.
Reiss K; Bhakdi S
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2082-2087. PubMed ID: 28624437
[TBL] [Abstract][Full Text] [Related]
16. PI3K Catalytic Isoform Alteration Promotes the LIMK1-related Metastasis Through the PAK1 or ROCK1/2 Activation in Cigarette Smoke-exposed Ovarian Cancer Cells.
Park GB; Kim D
Anticancer Res; 2017 Apr; 37(4):1805-1818. PubMed ID: 28373445
[TBL] [Abstract][Full Text] [Related]
17. Human and Murine Interleukin 23 Receptors Are Novel Substrates for A Disintegrin and Metalloproteases ADAM10 and ADAM17.
Franke M; Schröder J; Monhasery N; Ackfeld T; Hummel TM; Rabe B; Garbers C; Becker-Pauly C; Floss DM; Scheller J
J Biol Chem; 2016 May; 291(20):10551-61. PubMed ID: 26961870
[TBL] [Abstract][Full Text] [Related]
18. Effects of ADAM10 and ADAM17 Inhibitors on Natural Killer Cell Expansion and Antibody-dependent Cellular Cytotoxicity Against Breast Cancer Cells
Pham DH; Kim JS; Kim SK; Shin DJ; Uong NT; Hyun H; Yoon MS; Kang SJ; Ryu YJ; Cho JS; Yoon JH; Lee JS; Cho D; Lee SH; Park MH
Anticancer Res; 2017 Oct; 37(10):5507-5513. PubMed ID: 28982863
[TBL] [Abstract][Full Text] [Related]
19. ADAM10 and ADAM17-Novel Players in Retinoblastoma Carcinogenesis.
Van Meenen D; Doege A; Alefeld E; Haase A; Beier M; Kiefer T; Biewald E; Metz K; Dräger O; Busch MA; Dünker N
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293469
[TBL] [Abstract][Full Text] [Related]
20. GSK-3β-mediated fatty acid synthesis enhances epithelial to mesenchymal transition of TLR4-activated colorectal cancer cells through regulation of TAp63.
Park GB; Chung YH; Gong JH; Jin DH; Kim D
Int J Oncol; 2016 Nov; 49(5):2163-2172. PubMed ID: 27599658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
